Skip to main navigation Skip to search Skip to main content

Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor

  • Seattle Children's Research Institute
  • Infectious Disease Research Institute
  • Center for Global Infectious Disease
  • TB Discovery Research
  • University of Washington

Research output: Contribution to journalArticlepeer-review

Abstract

Indolcarboxamides are a promising series of anti-tubercular agents, which target Mycobacterium tuberculosis MmpL3, the exporter of trehalose monomycolate, a key cell-wall component. We determined the kill kinetics of the lead indolcarboxamide NITD-349 and determined that while kill was rapid against low-density cultures, bactericidal activity was inoculum-dependent. A combination of NITD-349 with isoniazid (which inhibits mycolate synthesis) had an increased kill rate; this combination prevented the appearance of resistant mutants, even at higher inocula.

Original languageEnglish
Article number001345
JournalMicrobiology (United Kingdom)
Volume169
Issue number6
DOIs
Publication statusPublished - 19 Jun 2023
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • anti-tubercular
  • bactericidal activity
  • cell-wall inhibitor
  • tuberculosis drug discovery

Fingerprint

Dive into the research topics of 'Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor'. Together they form a unique fingerprint.

Cite this